Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

593 Press Releases
DateTitleCompany
21 May 11 SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors Pfizer Inc.,
Published by
Business Wire
20 May 11 ELIQUIS® (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement Pfizer Inc.,
Published by
Business Wire
19 May 11 Pfizer Presents New Phase III Data Showing Axitinib Significantly Extended Progression-Free Survival Compared with Sorafenib in Patients with Previously-Treated Advanced Renal Cell Carcinoma Pfizer
19 May 11 Pfizer Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma Pfizer Inc.,
Published by
Business Wire
17 May 11 Pfizer Announces Simultaneous Filing Of New Drug Applications For Crizotinib With U.S. Food And Drug Administration And Japanese Ministry Of Health, Labour And Welfare Pfizer Inc.,
Published by
Business Wire
16 May 11 Pfizer To Present New Research From Fifteen Compounds Highlighting Multiple Approaches To Targeting Cancer At 2011 ASCO Annual Meeting Pfizer Inc.,
Published by
Business Wire
11 May 11 Pfizer Animal Health And American Humane Association Partner To Conduct Research On The Power Of The Human-Animal Bond In Pediatric Cancer Patients Pfizer Inc.,
Published by
Business Wire
10 May 11 Alzheimer’s Association Salutes Advocate And Mountaineer Now Climbing Everest As Part Of The 7 Summits Climb For Alzheimer’s Pfizer Inc.,
Published by
Business Wire
09 May 11 Pfizer’s Prevnar 13® Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented Today Pfizer Inc.,
Published by
Business Wire
09 May 11 Judges call for 2011 Pfizer Excellence in Oncology Award entries Pfizer Excellence in Oncology Awards
05 May 11 The European Commission Approves Pfizer’s Revatio® (sildenafil) for the Treatment of Pulmonary Arterial Hypertension in Children Pfizer Inc.,
Published by
Business Wire
03 May 11 PRISTIQ® (desvenlafaxine) Extended Release Tablets Shown To Significantly Reduce Number And Severity Of Moderate-To-Severe Hot Flashes Associated With Menopause Pfizer Inc.,
Published by
Business Wire
03 May 11 Pfizer Reports First-Quarter 2011 Results Pfizer Inc.,
Published by
Business Wire
02 May 11 Centrum® multivitamins and Celebrity Personal Trainer Harley Pasternak Share Star-Tested Secrets to Shape up for Summer Pfizer Inc.,
Published by
Business Wire
29 Apr 11 HealthMPowers Partners with Pfizer and Middle Georgia Medical Society to Launch “Empowering Healthy Choices”, a Multi-Year Health Promotion Pilot in Four Bibb County, Ga. Schools Pfizer Inc.,
Published by
Business Wire
28 Apr 11 Pfizer Hosts Annual Meeting of Shareholders Pfizer Inc.,
Published by
Business Wire
28 Apr 11 Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
27 Apr 11 Pfizer Launches New Advanced GOLD Range Of Early Child Nutrition Products Pfizer Inc.,
Published by
Business Wire
22 Apr 11 Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005 Pfizer Inc.,
Published by
Business Wire
21 Apr 11 Pfizer Invites Public To Listen To Webcast Of April 28 Annual Meeting Of Shareholders Pfizer Inc.,
Published by
Business Wire
20 Apr 11 Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership Pfizer Inc.,
Published by
Business Wire
15 Apr 11 Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
13 Apr 11 Tafamidis, An Oral, Investigational Compound For The Treatment Of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) Sustained A Slowing Of Disease Progression Over 30 Months Pfizer Inc.,
Published by
Business Wire
13 Apr 11 FDA Advisory Committee Finds Data Support The Favorable Benefit-Risk Profile Of SUTENT® In Unresectable Pancreatic Neuroendocrine Tumors (NET) Pfizer Inc.,
Published by
Business Wire
06 Apr 11 FIRST INJECTABLE TREATMENT INDICATED FOR DUPUYTREN'S CONTRACTURE, LAUNCHED IN UK Pfizer,
Published by
PharmiWeb.com
05 Apr 11 Pfizer Invites Public To View And Listen To Webcast Of May 3 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
05 Apr 11 Pfizer to Sell Capsugel to KKR Pfizer, KKR,
Published by
PharmiWeb.com
04 Apr 11 Pfizer to Sell Capsugel to KKR Pfizer,
Published by
Business Wire
04 Apr 11 Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application Pfizer Inc.,
Published by
Business Wire
01 Apr 11 Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010 Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.